2m 2m 2m 2m 2m 2m 2m
- $10.9BMarket Cap
- -19.23%1-Year Change
- Medical Instruments & SuppliesIndustry
COOPER CO (COO)
Key Performance
More- Earnings Score: 55
- Momentum Score: 14
- True Yield: N/A
- Financial Health Score: 64
Latest Research & News
Cooper Companies Director Kurzius Buys $549,300 in Shares. Is the Eye Care Stock About to Rally?
Lawrence Erik Kurzius, a Director at Cooper Companies, purchased 10,000 shares worth $549,300 at $54.93 per share on September 16, 2026, increasing his total holdings to 31,099 shares. The insider buy signals confidence in the company's recovery prospects following a 16% stock decline over the past year. The article notes that insider purchases typically predict higher share prices within 30 days and suggest management believes in the company's long-term growth, particularly after deciding to retain its surgical unit rather than divest it.
10/02/2026, 1:11 PM • The Motley Fool
Rosen Law Firm has announced an investigation into potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO) for allegedly issuing materially misleading business information. The investigation was triggered by CooperCompanies' disappointing earnings report on September 10, 2026, which included weak guidance and a decision not to sell CooperSurgical, causing the stock to fall 14.6%. Investors who purchased CooperCompanies securities may be eligible for compensation through a class action lawsuit.
09/25/2026, 9:05 PM • GlobeNewswire
Law firm Kirby McInerney LLP is investigating potential securities law violations by Cooper Companies following the company's September 9, 2026 earnings announcement. CooperCompanies reported Q3 revenue of $1.07 billion, missing analyst expectations of $1.10 billion, with its CooperVision segment showing flat year-over-year growth. The company attributed underperformance to proactive U.S. channel inventory reductions. The stock declined 14.7% on the news, falling from $63.48 to $54.17 per share.
09/15/2026, 3:33 PM • GlobeNewswire
The Cooper Companies' stock plummeted 14.6% on September 10, 2026, after Q3 2026 earnings revealed significant U.S. channel inventory destocking at its CooperVision segment. The company reduced full-year revenue guidance to flat or down 2% organically, attributing the decline entirely to inventory reductions. Hagens Berman has opened an investigation into whether Cooper was sufficiently transparent about its sales practices and potential securities law violations.
09/12/2026, 2:49 PM • GlobeNewswire
3 Undervalued Stocks to Buy in a Rotating Market
As the stock market rotates away from mega-cap tech, three undervalued stocks offer compelling opportunities: Keurig Dr Pepper trades at a discount to beverage peers with attractive dividend yield; Cooper Companies benefits from healthcare sector resilience with strong EPS growth prospects; and Matador Resources capitalizes on the energy sector's 21% YTD surge with robust revenue growth and cash flow metrics.
02/18/2026, 12:24 PM • Investing
3 Undervalued Stocks to Buy in a Rotating Market
As the stock market rotates away from mega-cap tech, three undervalued stocks offer compelling opportunities: Keurig Dr Pepper trades at a discount to beverage peers with attractive dividend yields; Cooper Companies benefits from healthcare sector resilience with strong EPS growth prospects; and Matador Resources capitalizes on the energy sector's 21% YTD surge with robust revenue growth and cash flow generation.
02/18/2026, 11:08 AM • Investing
3 Undervalued Stocks to Buy in a Rotating Market
As market leadership shifts and investors rotate away from mega-cap growth stocks, three undervalued companies offer compelling opportunities: Keurig Dr Pepper trades at a discount to beverage peers with attractive dividend yields; Cooper Companies benefits from healthcare sector resilience with strong EPS growth prospects; and Matador Resources capitalizes on the energy sector's 21% YTD surge with robust revenue growth and cash flow generation.
02/18/2026, 7:38 AM • Investing
3 Undervalued Stocks to Buy in a Rotating Market
As the stock market rotates away from mega-cap growth stocks, three undervalued companies offer compelling opportunities: Keurig Dr Pepper trades at a discount to beverage peers with attractive dividend yields; Cooper Companies benefits from healthcare sector resilience with strong EPS growth prospects; and Matador Resources capitalizes on the energy sector's 21% YTD surge with robust revenue growth and cash flow generation.
02/18/2026, 6:44 AM • Investing
The global ART market is projected to grow from $30.1 billion in 2024 to $60.7 billion by 2033 at a CAGR of 8.1%, driven by rising infertility prevalence, delayed parenthood, and expanding employer-sponsored fertility benefits. IVF dominates with 90% market share, while Europe leads with 35.80% of the global market. Over 450 Fortune 500 companies now offer fertility benefits, with specialized platforms facilitating over 500,000 virtual consultations in 2024.
01/27/2026, 1:41 PM • GlobeNewswire
The global contact lens market is projected to grow from USD 18.88 billion in 2025 to USD 26.64 billion by 2033, expanding at a CAGR of 4.42%. Growth is driven by rising myopia prevalence, increasing adoption of disposable lenses, and technological advancements in silicone hydrogel materials. However, risks from eye infections and user discomfort may hinder expansion. The U.S. market leads North America with expected growth to USD 6.83 billion by 2033.
01/16/2026, 7:00 AM • GlobeNewswire
Judge Denies Teva Bid To Pause Paragard Copper Contraceptive Device Lawsuit Trial
A Georgia federal judge denied Teva Pharmaceutical's request to delay the first trial in approximately 3,800 lawsuits alleging its Paragard copper IUD can fracture during removal. The trial is scheduled to proceed on January 20. The judge previously expressed concerns about Teva's five-year delay in complying with an FDA mandate to update warning labels and rejected the company's preemption defense arguments.
01/13/2026, 11:16 AM • Benzinga
CooperCompanies Appoints Walter M Rosebrough, Jr. to its Board of Directors
CooperCompanies announced the appointment of Walt M Rosebrough, Jr., former CEO of STERIS, as an independent director effective January 3, 2026, following a cooperation agreement with activist investor Browning West. Rosebrough will join the Corporate Governance & Nominating Committee with consideration for Board Chair by end of 2026. The company also committed to appointing a new independent director with medical technology experience.
12/23/2025, 8:00 AM • GlobeNewswire
Cooper Companies Launches Portfolio Review To 'Unlock Value'
Cooper Companies reported strong Q4 earnings, beating expectations, and announced a portfolio review to unlock long-term value. The company expects positive organic growth and raised fiscal 2026 guidance.
12/05/2025, 12:19 PM • Benzinga
U.S. stock futures recovered early losses ahead of the Federal Reserve's PCE inflation data. Netflix announced an $82.7 billion deal to acquire Warner Bros Discovery, while job cuts fell 53% month-over-month in November. Markets anticipate potential interest rate cuts in December.
12/05/2025, 8:33 AM • Benzinga
U.S. stock futures fluctuated on Friday as investors anticipate the September PCE price index. Job cuts fell 53% month-over-month in November, and markets expect a potential Federal Reserve interest rate cut in December.
12/05/2025, 5:28 AM • Benzinga
Peers
Statistics
MoreInformation as of 10/02/2026
Company Profile
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Key Executives
- Albert G. White
- Daniel G. McBride
- Brian G. Andrews
- Holly R. Sheffield
- Gerard H. Warner
Current Ownership Distribution
- Institutions2.3B (53.60%)
- Mutual Funds2.0B (46.36%)
- Insiders1.8M (0.04%)
- Other0 (0.00%)